Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Entera Bio Ltd. (ENTX)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $42,000 | $181,000 | $0 | $134,000 | $571,000 | $365,000 | $236,000 | $500,000 | — | — |
| Gross profit | $0 | $9,000 | $0 | $33,000 | $198,000 | $65,000 | — | — | — | — |
| Research & development | $6.0M | $4.5M | $4.5M | $5.8M | $6.8M | $6.4M | $7.2M | $8.5M | $2.8M | $2.6M |
| Operating expenses | $11.5M | $9.6M | $8.9M | $13.1M | $12.4M | $11.2M | — | — | — | — |
| Operating income | −$11.5M | −$9.6M | −$8.9M | −$13.0M | −$12.2M | −$11.2M | −$11.5M | −$10.9M | −$11.3M | −$5.4M |
| EBITDAderived | — | — | — | — | — | −$10.9M | −$11.2M | −$10.8M | −$11.3M | −$5.3M |
| Net income | −$11.4M | −$9.5M | −$8.9M | −$13.1M | −$12.2M | −$11.2M | −$10.8M | −$10.3M | −$11.2M | −$1.2M |
| Basic EPSper diluted share | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | $0.89 | $1.30 | $2.49 | $0.27 |
| Diluted EPSper diluted share | $0.25 | $0.25 | $0.31 | $0.45 | $0.47 | $0.67 | $0.89 | $1.31 | $2.49 | $0.78 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 9, 2026Form 4 | Germano Geno JDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 20.0K | $1.30 | $26.0K | 40.0K |
| Mar 5, 2026Form 4 | Ellis SeanDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 10.0K | $1.23 | $12.3K | 188.1K |
| Feb 12, 2026Form 4 | Rubin Steven DDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 5.0K | $1.49 | $7.5K | 15.0K |
| Feb 10, 2026Form 4 | Taitel HayaDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 7.5K | $1.48 | $11.1K | — |
| Feb 10, 2026Form 4 | Germano Geno JDirector | BuyOrdinary Shares, par value NIS 0.0000769 per share | 20.0K | $1.49 | $29.8K | — |